Drug
Endoxifen
Endoxifen: highest development phase Phase 2, developed by Atossa Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Atossa Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| (Z)-endoxifen NCT05607004 | Phase 2 | Breast Neoplasms |
| (Z)-endoxifen NCT07869732 | Phase 2 | Precocious Puberty, Gonadotropin-dependent |
Latest
No recent events.
Follow Endoxifen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.